IP Library Granted Patent US 8,546,553
Granted Patent B2
US 8,546,553 · App. 13/055,769 · Granted Oct 1, 2013

Prokaryotic RNAi-like system and methods of use

Inventors: Rebecca Terns (Athens, GA); Michael Terns (Athens, GA); Caryn Hale (Athens, GA)
Assignee: University of Georgia Research Foundation, Inc.
C12N15/113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,546,553
App. No.
13/055,769
Filed
Apr 1, 2011
Granted
Oct 1, 2013
Kind
B2
Examiner
SHIN, DANA H
Art Unit
1635
USPC
536/24.5
Abstract

Provided herein are methods for inactivating a target polynucleotide. The methods use a psiRNA having a 5′ region and a 3′ region. The 5′ region includes, but is not limited to, 5 to 10 nucleotides chosen from a repeat from a CRISPR locus immediately upstream of a spacer. The 3′ region is substantially complementary to a portion of the target polynucleotide. The methods may be practiced in a prokaryotic microbe or in vitro. Also provided are polypeptides that have endonuclease activity in the presence of a psiRNA and a target polynucleotide, and methods for using the polypeptides.

Claims (10)

1. An isolated polynucleotide comprising at least 23 nucleotides, wherein the isolated polynucleotide comprises a psiRNA-tag and a guide sequence, wherein the psiRNA-tag is the first 5 to 10 nucleotides of the isolated polynucleotide and comprises a nucleotide sequence chosen from nucleotides of a repeat from a CRISPR locus that are immediately upstream of a spacer present in a microbe comprising the CRISPR locus, wherein the guide sequence is located immediately downstream of the psiRNA-tag and comprises the remaining nucleotides of the isolated polynucleotide, and wherein the guide sequence is complementary to, and hybridizes to, a target polynucleotide which is cleaved.

2. A vector encoding the isolated polynucleotide of claim 1 .

3. The isolated polynucleotide of claim 1 wherein the isolated polynucleotide is RNA.

4. The isolated polynucleotide of claim 1 wherein the psiRNA-tag has at least 80% sequence similarity with 5′-ATTGAAAS, wherein S is G or C.

5. The isolated polynucleotide of claim 1 wherein the guide sequence comprises at least 31 nucleotides or at least 37 nucleotides.

6. The isolated polynucleotide of claim 1 wherein the guide sequence is 31 nucleotides or is 37 nucleotides.

7. The isolated polynucleotide of claim 1 wherein the psiRNA-tag is the first 8 nucleotides of the isolated polynucleotide.

8. The isolated polynucleotide of claim 1 wherein the target polynucleotide is RNA.

9. The isolated polynucleotide of claim 1 wherein the isolated polynucleotide is associated with CRISPR-associated (Cas) polypeptides to form a complex having endonuclease activity, and wherein the Cas polypeptides are encoded by the microbe.

10. The isolated polynucleotide of claim 9 wherein the Cas polypeptides comprise a Cmr1 polypeptide, a Cmr2 polypeptide, a Cmr3 polypeptide, a Cmr4 polypeptide, and a Cmr6 polypeptide, and have endoribonuclease activity.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 26, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045165/0826 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2011
From: TERNS, REBECCA M.; TERNS, MICHAEL P.; HALE, CARYN R.
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 026148/0830 →
Continuity (4)
Provisional Application 61083616 · Jul 25, 2008
Provisional Application 61180656 · May 22, 2009
Provisional Application 61227554 · Jul 22, 2009
Related Publication 20110189776A1 · Aug 4, 2011